Factive Should Be Used Second-Line For Treatment Of Acute Sinusitis – Cmte.

Oscient's Factive would be a second-line treatment of acute bacterial sinusitis, FDA's Anti-Infective Drugs Advisory Committee said in recommending against approval of a supplemental claim for gemifloxacin in ABS Sept. 12.